News FDA clears lifesaving feature for Google's Pixel Watch 3 The FDA has approved loss of pulse detection for Google's Pixel Watch 3, almost six months after the smartwatch was launched in the US.
Patients Bringing parity to infertility, with Jean Duvall During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.